Marker Therapeutics Statistics
Total Valuation
MRKR has a market cap or net worth of $23.01 million. The enterprise value is $5.42 million.
Important Dates
The next estimated earnings date is Monday, March 30, 2026, before market open.
| Earnings Date | Mar 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MRKR has 16.67 million shares outstanding. The number of shares has increased by 43.29% in one year.
| Current Share Class | 16.67M |
| Shares Outstanding | 16.67M |
| Shares Change (YoY) | +43.29% |
| Shares Change (QoQ) | +20.07% |
| Owned by Insiders (%) | 7.42% |
| Owned by Institutions (%) | 14.54% |
| Float | 13.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.90 |
| Forward PS | 9.09 |
| PB Ratio | 1.25 |
| P/TBV Ratio | 1.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.50
| Current Ratio | 6.50 |
| Quick Ratio | 5.75 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -110.67% and return on invested capital (ROIC) is -69.73%.
| Return on Equity (ROE) | -110.67% |
| Return on Assets (ROA) | -55.19% |
| Return on Invested Capital (ROIC) | -69.73% |
| Return on Capital Employed (ROCE) | -78.39% |
| Weighted Average Cost of Capital (WACC) | 12.25% |
| Revenue Per Employee | $938,998 |
| Profits Per Employee | -$2.86M |
| Employee Count | 5 |
| Asset Turnover | 0.29 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MRKR has paid $49,953 in taxes.
| Income Tax | 49,953 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.00% in the last 52 weeks. The beta is 1.45, so MRKR's price volatility has been higher than the market average.
| Beta (5Y) | 1.45 |
| 52-Week Price Change | -25.00% |
| 50-Day Moving Average | 1.65 |
| 200-Day Moving Average | 1.33 |
| Relative Strength Index (RSI) | 41.46 |
| Average Volume (20 Days) | 155,429 |
Short Selling Information
The latest short interest is 586,941, so 3.52% of the outstanding shares have been sold short.
| Short Interest | 586,941 |
| Short Previous Month | 255,701 |
| Short % of Shares Out | 3.52% |
| Short % of Float | 4.25% |
| Short Ratio (days to cover) | 1.53 |
Income Statement
In the last 12 months, MRKR had revenue of $4.69 million and -$14.30 million in losses. Loss per share was -$1.12.
| Revenue | 4.69M |
| Gross Profit | -9.07M |
| Operating Income | -14.41M |
| Pretax Income | -14.25M |
| Net Income | -14.30M |
| EBITDA | n/a |
| EBIT | -14.41M |
| Loss Per Share | -$1.12 |
Full Income StatementBalance Sheet
The company has $17.59 million in cash and n/a in debt, with a net cash position of $17.59 million or $1.05 per share.
| Cash & Cash Equivalents | 17.59M |
| Total Debt | n/a |
| Net Cash | 17.59M |
| Net Cash Per Share | $1.05 |
| Equity (Book Value) | 18.39M |
| Book Value Per Share | 1.10 |
| Working Capital | 18.39M |
Full Balance SheetCash Flow
| Operating Cash Flow | -14.82M |
| Capital Expenditures | n/a |
| Free Cash Flow | -14.82M |
| FCF Per Share | -$0.89 |
Full Cash Flow StatementMargins
| Gross Margin | -193.12% |
| Operating Margin | -307.02% |
| Pretax Margin | -303.47% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MRKR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -43.29% |
| Shareholder Yield | -43.29% |
| Earnings Yield | -62.14% |
| FCF Yield | -64.40% |
Analyst Forecast
The average price target for MRKR is $11.25, which is 715.22% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.25 |
| Price Target Difference | 715.22% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 91.32% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 27, 2023. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jan 27, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
MRKR has an Altman Z-Score of -26.79 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -26.79 |
| Piotroski F-Score | 1 |
